ID
38917
Descripción
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders This phase II, placebo-controlled, double-blind trial studies the polysomnographic and subjective effect of the neurokinin (NK1) antagonist vestipitant (15mg/day at bedtime) for the treatment of primary insomnia in adult outpatients over a period of four weeks. The study consists of a clinical Screening Visit (Visit 1), up to 21 days before investigational product/placebo initiation, two screening polysomnographies (Visits 2 and 3), followed by a placebo run-in until Visit 4, at which the subject is randomized to vestipitant or placebo, taken every night for 28 days. On Day 1 and 2 (Visits 4 and 5), polysomnographies are performed. Visit 6 is a safety visit on Day 15. On Day 27 and 28, Visits 7 and 8 are performed, which again include polysomnography studies. Subjects then undergo a 7 to 10 day placebo run-out period and have Day 7 and Day 14 Follow-Up Visit (Visits 9 and 10). This form is to be filled in continously during the study and/or at the Day 14 Follow-up evaluation and contains information on other medication the participant has received during the course of the study.
Link
https://clinicaltrials.gov/ct2/show/NCT00992160
Palabras clave
Versiones (1)
- 12.11.19 12.11.19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
12. November 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Concomitant Medications
- StudyEvent: ODM
Descripción
Concomitant Medications
Alias
- UMLS CUI-1
- C2347852 (Concomitant Agent)
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2348184 (Sequence Number)
Descripción
Trade Name preferred
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2360065 (Medication name)
- LOINC
- MTHU027854
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826819 (Concomitant Medication Modified Reported Term)
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
- UMLS CUI [1,2]
- C0871468 (Synonym)
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
- UMLS CUI [1,2]
- C1516698 (Collection (action))
- LOINC
- LP20988-9
- UMLS CUI [1,3]
- C0805701 (Code)
Descripción
[hidden]
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0805701 (Code)
- UMLS CUI [1,2]
- C0231175 (Failed)
Descripción
Concomitant Medication Unit Dose
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826811 (Concomitant Medication Dose)
Descripción
Concomitant Medication Units
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826646 (Concomitant Medication Dose Unit)
Descripción
Concomitant Medication Frequency
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826654 (Concomitant Medication Dose Frequency)
Descripción
Concomitant Medication Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826730 (Concomitant Medication Route of Administration)
Descripción
Concomitant Medication reason
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826696 (Concomitant Medication Use Indication)
Descripción
Concomitant Medication start date/time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C2826825 (Concomitant Medication Use Start Date Time)
Descripción
Concomitant Medication Taken Prior to Study?
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826667 (Concomitant Medication Previous Occurrence)
Descripción
If no, specify End Date and Time
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826666 (Concomitant Medication Ongoing)
Descripción
Concomitant Medication end date/time
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C2826815 (Concomitant Medication Use End Date Time)
Similar models
Concomitant Medications
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0871468 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,2])
Sin comentarios